Follow
Farhana Sakloth
Farhana Sakloth
Department of Neuroscience.Icahn School of Medicine at Mount Sinai
Verified email at mssm.edu
Title
Cited by
Cited by
Year
“Deconstruction” of the abused synthetic cathinone methylenedioxypyrovalerone (MDPV) and an examination of effects at the human dopamine transporter
R Kolanos, E Solis Jr, F Sakloth, LJ De Felice, RA Glennon
ACS chemical neuroscience 4 (12), 1524-1529, 2013
832013
Structural modification of the designer stimulant α-pyrrolidinovalerophenone (α-PVP) influences potency at dopamine transporters
R Kolanos, F Sakloth, AD Jain, JS Partilla, MH Baumann, RA Glennon
ACS chemical neuroscience 6 (10), 1726-1731, 2015
822015
Quantitative structure–activity relationship analysis of the pharmacology of para‐substituted methcathinone analogues
JS Bonano, ML Banks, R Kolanos, F Sakloth, ML Barnier, RA Glennon, ...
British journal of pharmacology 172 (10), 2433-2444, 2015
692015
Abuse-related neurochemical effects of para-substituted methcathinone analogs in rats: microdialysis studies of nucleus accumbens dopamine and serotonin
JA Suyama, F Sakloth, R Kolanos, RA Glennon, MF Lazenka, SS Negus, ...
Journal of Pharmacology and Experimental Therapeutics 356 (1), 182-190, 2016
602016
Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para‐substituted methcathinone analogues
F Sakloth, R Kolanos, PD Mosier, JS Bonano, ML Banks, JS Partilla, ...
British journal of pharmacology 172 (9), 2210-2218, 2015
522015
Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.
F Sakloth, E Leggett, MJ Moerke, EA Townsend, ML Banks, SS Negus
Experimental and clinical psychopharmacology 27 (3), 215, 2019
472019
N-Alkylated analogs of 4-methylamphetamine (4-MA) differentially affect monoamine transporters and abuse liability
E Solis, JS Partilla, F Sakloth, I Ruchala, KL Schwienteck, LJ De Felice, ...
Neuropsychopharmacology 42 (10), 1950-1961, 2017
352017
RGS4 maintains chronic pain symptoms in rodent models
K Avrampou, KD Pryce, A Ramakrishnan, F Sakloth, S Gaspari, ...
Journal of Neuroscience 39 (42), 8291-8304, 2019
312019
Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway
S Gaspari, I Purushothaman, V Cogliani, F Sakloth, RL Neve, D Howland, ...
Proceedings of the National Academy of Sciences 115 (9), E2085-E2094, 2018
292018
HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice
F Sakloth, L Manouras, K Avrampou, V Mitsi, RA Serafini, KD Pryce, ...
Psychopharmacology 237, 2139-2149, 2020
272020
Regulators of G protein signaling in analgesia and addiction
F Sakloth, C Polizu, F Bertherat, V Zachariou
Molecular Pharmacology 98 (6), 739-750, 2020
232020
A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects
KD Pryce, HJ Kang, F Sakloth, Y Liu, S Khan, K Toth, A Kapoor, A Nicolais, ...
Neuropharmacology 195, 108673, 2021
182021
Investigation of the optical isomers of methcathinone, and two achiral analogs, at monoamine transporters and in intracranial self-stimulation studies in rats
RA Davies, TR Baird, VT Nguyen, B Ruiz, F Sakloth, JM Eltit, SS Negus, ...
ACS chemical neuroscience 11 (12), 1762-1769, 2020
122020
Effects of N-Alkyl-4-Methylamphetamine Optical Isomers on Plasma Membrane Monoamine Transporters and Abuse-Related Behavior
UM Battisti, R Sitta, A Harris, F Sakloth, D Walther, I Ruchala, SS Negus, ...
ACS chemical neuroscience 9 (7), 1829-1839, 2018
122018
Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog …
F Del Bello, F Sakloth, JS Partilla, MH Baumann, RA Glennon
Bioorganic & medicinal chemistry 23 (17), 5574-5579, 2015
102015
Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats.
F Sakloth, SS Negus
Experimental and clinical psychopharmacology 26 (2), 195, 2018
92018
Oxycodone withdrawal induces HDAC1/HDAC2-dependent transcriptional maladaptations in the reward pathway in a mouse model of peripheral nerve injury
KD Pryce, RA Serafini, A Ramakrishnan, A Nicolais, IM Giosan, C Polizu, ...
Nature neuroscience 26 (7), 1229-1244, 2023
52023
Tianeptine promotes lasting antiallodynic effects in a mouse model of neuropathic pain
RA Serafini, M Estill, EA Pekarskaya, F Sakloth, L Shen, JA Javitch, ...
Neuropsychopharmacology 48 (11), 1680-1689, 2023
32023
Psychoactive synthetic cathinones (or'bath salts'): Investigation of mechanisms of action
F Sakloth
Virginia Commonwealth University, 2015
32015
A regional and projection-specific role of RGSz1 in the ventrolateral periaqueductal grey in the modulation of morphine reward
F Sakloth, OB Sanchez-Reyes, A Ruiz, A Nicolais, RA Serafini, KD Pryce, ...
Molecular Pharmacology 103 (1), 1-8, 2023
22023
The system can't perform the operation now. Try again later.
Articles 1–20